Search results for "Optic neuropathy"

showing 3 items of 23 documents

Optic neuropathy caused by type A botulinic toxin

2014

Purpose To report the development of an optical neuropathy after injection of type A botulinic toxin in a subject with blepharospasm. Methods Optical neuropathy was evaluated through a complete ophthalmologic examination consisting of bio-microscopy, tonometry and study of visual sharpness, colour test, visual field, OCT, fluorangiography and determination of VEPs. Results Intravenous therapy was begun with Metilprednisolone (20 mg/Kg/day) and Vitamin B6 associated with oral Citicoline, and there was a clear improvement down to normalization of the symptoms. After 6 months the Humphrey computerized visual field with central 30-2 program threshold test emphasised in ODx an upper half-field a…

medicine.medical_specialtygenetic structuresmedicine.diagnostic_testbusiness.industryThreshold testSettore MED/30 - Malattie Apparato VisivoBlepharospasmGeneral MedicineBlepharospasm Type A botulinic toxin Optic neuropathymedicine.diseaseeye diseasesSurgeryVisual fieldOptic neuropathyMajor duodenal papillaPerimeterOphthalmologyOptical coherence tomographyOphthalmologyFixation (visual)medicineType A botulinic toxinsense organsmedicine.symptombusiness
researchProduct

Orbital Decompression for Endocrine Ophthalmopathy: The Endonasal Approach

1994

A surgical endonasal procedure is described to perform orbital decompression in patients suffering from ophthalmopathy in Grave's disease. The decompression technique employs removal of the lamina papyracea as an exclusive modality or in conjunction with a transmaxillary or lateral decompression approach. This present series contain 23 patients who underwent decompression over a 3-year period and were followed for at least 6 months postoperative. The results of decompression were assessed by measuring reduction in proptosis and visual acuity. All patients demonstrated improved visual acuity. Measuring retroplacement of the globe, the endonasal approach proved to equal the results obtained …

musculoskeletal diseasesmedicine.medical_specialtyVisual acuitygenetic structuresbusiness.industryDecompressionmedicine.medical_treatmentOrbital decompressionmedicine.diseaseeye diseasesSurgeryOptic neuropathy03 medical and health sciences0302 clinical medicineOtorhinolaryngology030220 oncology & carcinogenesismedicineIn patientEndocrine ophthalmopathymedicine.symptom030223 otorhinolaryngologyTraining programbusinessReduction (orthopedic surgery)American Journal of Rhinology
researchProduct

IMI Prevention of Myopia and Its Progression

2021

The prevalence of myopia has markedly increased in East and Southeast Asia, and pathologic consequences of myopia, including myopic maculopathy and high myopia-associated optic neuropathy, are now some of the most common causes of irreversible blindness. Hence, strategies are warranted to reduce the prevalence of myopia and the progression to high myopia because this is the main modifiable risk factor for pathologic myopia. On the basis of published population-based and interventional studies, an important strategy to reduce the development of myopia is encouraging schoolchildren to spend more time outdoors. As compared with other measures, spending more time outdoors is the safest strategy…

ulkoilugenetic structuresContact Lensesmedicine.medical_treatmenttaittovirheetehkäisyatropinePopulationVisual impairmentlikinäköisyysorthokeratologyGlobal HealthRefraction Ocularmyopia-associated optic neuropathyOptic neuropathy03 medical and health sciences0302 clinical medicineMyopiaPrevalencemedicineHumansRisk factorhigh myopiaeducationeducation.field_of_studySpecial Issuebusiness.industrypathologic myopiamyopic macular degenerationOrthokeratologyAccommodation Ocularpiilolasitmedicine.diseaseeye diseasesAmplitude of accommodationEyeglassesDisease Progression030221 ophthalmology & optometryOptometryMaculopathysense organsmedicine.symptombusinessAccommodation030217 neurology & neurosurgeryInvestigative Opthalmology & Visual Science
researchProduct